Perucchini D, Caduff R, Schär G, Fink D, Köchli O R
Department Frauenheilkunde, Universitätsspital Zürich.
Geburtshilfe Frauenheilkd. 1996 Jul;56(7):351-6. doi: 10.1055/s-2007-1023267.
37 cases of extragenital tumours metastatic to the ovaries are analysed from a clinicopathological viewpoint. In 25 out of 334 patients who were operated on between 1978 and 1990 because of a palpable malignant ovarian tumour, ovarian involvement from extragenital cancer was diagnosed. The most frequent primary sites were the stomach (n = 7), colon (n = 6) and breast (n = 6). 4 of the 6 patients with metastatic colon carcinoma had previously documented diagnosis of colon cancer with a time interval between diagnosis of primary tumours and secondary ovarian tumour ranging up to 11 years. Only one patient had a previously known stomach cancer, operated on 32 months earlier. All our patients with gastrointestinal primary tumour died within 1 year (gastric origin) of detection of metastases and 2 years (colon carcinoma) except for one patient with metastasis of colon carcinoma, who is still living after more than 4 years and one patient with gastric carcinoma who survived 34 months after oophorectomy. Surprisingly, ovarian metastases of breast cancer were detected before the primary tumour in 2 out of 6 cases. The other 4 patients were operated on because of an ovarian tumour but had a known and previously operated breast cancer. 27 patients had therapeutic ovarian ablation in metastatic breast cancer without a palpable pelvic mass. None of these patients had symptoms related to the ovaries. In 12 (40%) patients we found microscopic metastases which were bilateral in 9 cases. Metastases to the ovary may not infrequently mimic primary ovarian tumour and are difficult to diagnose preoperatively. We hope that some clinical features described by us (nationality, patient's history, bilateral ovarian tumours in young women) will alert the clinician to investigate further in order to achieve the best possible therapeutic management, because some patients may benefit from adequate treatment and survive for a long time.
从临床病理学角度分析了37例生殖器外肿瘤转移至卵巢的病例。在1978年至1990年间因可触及的恶性卵巢肿瘤而接受手术的334例患者中,有25例被诊断为生殖器外癌症累及卵巢。最常见的原发部位是胃(n = 7)、结肠(n = 6)和乳腺(n = 6)。6例转移性结肠癌患者中有4例先前已确诊为结肠癌,原发性肿瘤诊断与继发性卵巢肿瘤之间的时间间隔长达11年。只有1例患者先前已知患有胃癌,于32个月前接受了手术。除1例结肠癌转移患者在发现转移后4年多仍存活以及1例胃癌患者在卵巢切除术后存活34个月外,所有胃肠道原发性肿瘤患者均在检测到转移后1年(胃原发)和2年(结肠癌)内死亡。令人惊讶的是,6例乳腺癌患者中有2例卵巢转移在原发性肿瘤之前被检测到。其他4例患者因卵巢肿瘤接受手术,但已知并曾接受过乳腺癌手术。27例转移性乳腺癌患者在无明显盆腔肿块的情况下接受了治疗性卵巢切除术。这些患者均无与卵巢相关的症状。在12例(40%)患者中我们发现了微小转移灶,其中9例为双侧转移。卵巢转移可能经常酷似原发性卵巢肿瘤,术前难以诊断。我们希望我们所描述的一些临床特征(国籍、患者病史、年轻女性双侧卵巢肿瘤)能提醒临床医生进一步调查,以便实现最佳的治疗管理,因为一些患者可能从适当的治疗中获益并长期存活。